Pepti Review: $99 Semaglutide, One Big Caveat

Pepti (hellopepti.com) sells compounded semaglutide at $99 a month and tirzepatide at $199, flat at every titration dose, cancel any time. On a board built around what treatment actually costs, that is the most interesting number in this batch of seven providers. It is also the one we can least confidently guarantee, and the reason why sits in Pepti's own production data.

The headline, and where it comes from

We do not read prices off marketing copy. Pepti renders as a single-page app, so its catalogue was pulled from the JavaScript bundle: 68 products with a monthly price attached to each.¹ Semaglutide injectable is $99 a month, tirzepatide injectable is $199, and both are flat across every dose — the site's own cost page says so in as many words, and the same figures repeat on three cross-sell surfaces. A one-time purchase is available at exactly 1.25 times the subscription price, which checks out on every SKU we tested.

Cancellation is genuinely month to month: cancel any time, effective at the end of the cycle, with an option to pause for up to 90 days. There is no minimum term and no prepay tier, so there is nothing here for a commitment discount to hide inside. Six months of semaglutide is $594. Six months of tirzepatide is $1,194.

⚠ The caveat, stated straight

Sitting in the server payload for Pepti's own semaglutide and tirzepatide pages is a second price list — a per-dose ladder running $299, $349, $399 and $449 for semaglutide and $349, $399, $449 and $549 for tirzepatide. Nothing on the site renders it. No client-side code we downloaded reads it. It is not purchasable through any surface we could reach.

We tried to break the tie at the checkout and could not: the checkout endpoint accepts POST only, so there is no way to ask it what a real order costs without placing one. So we are reporting this exactly as we found it. **The rendered, corroborated price on every surface we could reach is $99 and $199. A per-dose ladder averaging roughly three times that headline is sitting in production data, unrendered, and we do not know why.** Whether $99 is what a checkout actually charges is the one thing we could not establish. It may be an abandoned pricing model. It may be what a checkout actually charges. We did not resolve it, and a savings board that quietly picked the flattering answer would be doing the thing this site exists to catch.

What that means practically: treat $99 as verified-as-displayed rather than verified-at-checkout, and read the number on your order confirmation before your card is charged a second time. If it is not $99, you have found the answer we could not.

When you are actually charged

Pepti's how-it-works page says you do not pay anything until a physician approves your treatment. Its refund policy says payment is collected at checkout, before the provider reviews your intake. Those are opposite claims on the same site. The refund policy is the operative document, so plan on being charged first and refunded — in five to ten business days — if you are declined. Once medication ships there are no refunds, and cancelling does not prorate.

36 states, not 50

Four separate pages — the shipping page, the state-availability page, the legal shipping terms and the providers page — publish the same list of 36 states, and the homepage title states that number without listing them. The terms of service say the service is available in all 50. Four corroborations beat one outlier, so we treat 36 as operative: Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Kansas, Kentucky, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Vermont, Virginia and Washington. At-home blood panels ship to all 50.

Who is prescribing, and who is compounding

Two physicians are named with full bios, board certifications and state licence counts — Dr. Gene Lee, family medicine, and Dr. Laeeq Butt, internal medicine. Neither publishes an NPI, so neither can be checked against the federal registry. That is a step better than the providers in this batch who name nobody, and a step worse than the ones whose director's NPI verifies.

The pharmacy is never named. The site describes "independent FDA-registered 503A or 503B compounding pharmacies" and stops there. At $99 a month that gap deserves more weight than it would at $299 — the whole argument of is cheap compounded GLP-1 safe? is that a low price is a reason to check the supply chain harder, not a reason to skip it, and how to verify a compounding pharmacy is legitimate is the check you cannot run here because there is no name to run it on.

The corporate address is a Newark, Delaware suite that is a well-known registered-agent address rather than an operating site.

The parts of the catalogue we would not touch

68 SKUs is a very wide shelf, and some of it should not be on it. Pepti sells retatrutide at $399 a month, plus melanotan II and IGF-1 LR3. Retatrutide has no FDA approval in any form anywhere — the reasons are laid out in is retatrutide available, and is it safe to buy now? — and none of those three belongs on a shortlist. Their presence on the same storefront as the $99 semaglutide is a fact about the operator, not a reason to discount the semaglutide price, but it is a fact worth knowing.

The regulatory screen

The trading name and the legal entity both returned zero company-column matches in the FDA's live warning-letter index in August 2026.² Worth noting what surrounds them: a search on the word "pepti" returns 45 rows, and several peptide sellers in that neighbourhood do carry letters. Pepti is not among them. The pass carried a positive control that correctly returned a known February 2026 letter for an unrelated seller, so the zero is evidence rather than a failed query.

The verdict for a bargain hunter

$99 a month is $51 below the next-cheapest standard-dose semaglutide rung we found in this batch — Trellis at $150 — and roughly half of what The Edit charges. Two microdose and low-dose rungs in the same batch sit at $149, but those are smaller doses, not the same product. If it holds at checkout, it is the best GLP-1 deal here by a wide margin. If it does not hold, the unrendered ladder says you could be looking at $299 and up, which would make it one of the worst. We could not settle it, so we are not going to rank it as settled. Check the ladder against everything else on the semaglutide price ladder, read your first invoice carefully, and treat the rest of our research as the background you should have before you buy anything compounded.